Exploring the Relationship Between Patient Activation, Treatment Satisfaction, and Decisional Conflict in Patients Approaching End-Stage Renal Disease.


Journal

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine
ISSN: 1532-4796
Titre abrégé: Ann Behav Med
Pays: England
ID NLM: 8510246

Informations de publication

Date de publication:
16 08 2019
Historique:
pubmed: 12 12 2018
medline: 17 9 2020
entrez: 12 12 2018
Statut: ppublish

Résumé

Patients approaching end-stage renal disease (ESRD) experience a high level of decisional conflict because they are often not provided with sufficient support and information regarding different treatment options prior to renal failure. Decisional conflict is an important correlate of treatment satisfaction, as it is associated with disease- and treatment-related knowledge that can inform decision-making. Patient activation, the willingness and ability to independently manage one's own health and healthcare, is an individual difference factor that may have important mitigating effects on decisional conflict. To identify modifiable factors that may enhance the decision-making process in patients approaching ESRD by exploring potential mediational effects between decisional conflict, treatment satisfaction, and patient activation. Sixty-four patients approaching ESRD completed self-report measures (32% response rate). Measures included the Decisional Conflict Scale, the Kidney Disease Treatment Questionnaire, and the Patient Activation Measure Short Form. There was a high level of self-reported decisional conflict in this sample. Linear regressions revealed main effects among treatment satisfaction, patient activation, and decisional conflict. These variables were entered into PROCESS to assess a mediational pattern. Results showed that higher chronic kidney disease-related treatment satisfaction predicted lower decisional conflict through higher patient activation in a statistical mediational relationship. While the link between treatment satisfaction and decision-making is well established, these results suggest this relationship might be partially explained by patient activation, a potentially modifiable process in patients approaching ESRD. Therefore, interventions that encourage patients to become actively involved in their care could also reduce decisional conflict among patients approaching ESRD.

Sections du résumé

BACKGROUND
Patients approaching end-stage renal disease (ESRD) experience a high level of decisional conflict because they are often not provided with sufficient support and information regarding different treatment options prior to renal failure. Decisional conflict is an important correlate of treatment satisfaction, as it is associated with disease- and treatment-related knowledge that can inform decision-making. Patient activation, the willingness and ability to independently manage one's own health and healthcare, is an individual difference factor that may have important mitigating effects on decisional conflict.
PURPOSE
To identify modifiable factors that may enhance the decision-making process in patients approaching ESRD by exploring potential mediational effects between decisional conflict, treatment satisfaction, and patient activation.
METHODS
Sixty-four patients approaching ESRD completed self-report measures (32% response rate). Measures included the Decisional Conflict Scale, the Kidney Disease Treatment Questionnaire, and the Patient Activation Measure Short Form.
RESULTS
There was a high level of self-reported decisional conflict in this sample. Linear regressions revealed main effects among treatment satisfaction, patient activation, and decisional conflict. These variables were entered into PROCESS to assess a mediational pattern. Results showed that higher chronic kidney disease-related treatment satisfaction predicted lower decisional conflict through higher patient activation in a statistical mediational relationship.
CONCLUSIONS
While the link between treatment satisfaction and decision-making is well established, these results suggest this relationship might be partially explained by patient activation, a potentially modifiable process in patients approaching ESRD. Therefore, interventions that encourage patients to become actively involved in their care could also reduce decisional conflict among patients approaching ESRD.

Identifiants

pubmed: 30535065
pii: 5236807
doi: 10.1093/abm/kay091
pmc: PMC6937620
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

816-826

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM108540
Pays : United States

Informations de copyright

© Society of Behavioral Medicine 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

BMJ Open. 2016 Jun 28;6(6):e011490
pubmed: 27354076
Health Aff (Millwood). 2013 Feb;32(2):207-14
pubmed: 23381511
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
J Clin Nurs. 2018 Jan;27(1-2):e138-e146
pubmed: 28543737
Psychother Psychosom. 2008;77(4):219-26
pubmed: 18418028
Clin Transplant. 2017 Jul;31(7):
pubmed: 28457025
Trials. 2015 May 27;16:231
pubmed: 26012700
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30
pubmed: 16336556
Health Psychol. 2008 Nov;27(6):711-721
pubmed: 19025266
BMC Med Inform Decis Mak. 2013;13 Suppl 2:S8
pubmed: 24625261
N Engl J Med. 2010 Nov 4;363(19):1833-45
pubmed: 21047227
Med Decis Making. 1995 Jan-Mar;15(1):25-30
pubmed: 7898294
Transplant Proc. 2015 Jun;47(5):1388-91
pubmed: 26093725
Palliat Med. 2017 Dec;31(10):921-931
pubmed: 28417662
Patient Educ Couns. 2017 Jul;100(7):1276-1279
pubmed: 28330715
BMJ. 2010 Jan 19;340:c112
pubmed: 20085970
J Cardiovasc Nurs. 2013 Jan-Feb;28(1):20-34
pubmed: 22343209
BMC Health Serv Res. 2013 Jun 25;13:231
pubmed: 23800366
Kidney Int. 1999 Oct;56(4):1551-9
pubmed: 10504507
J Palliat Med. 2012 Feb;15(2):228-35
pubmed: 22313460
Nephrol Dial Transplant. 2007 Jul;22(7):1955-62
pubmed: 17412702
Patient Educ Couns. 2009 Aug;76(2):149-58
pubmed: 19324509
Patient Prefer Adherence. 2012;6:39-48
pubmed: 22272068
BMJ. 1999 Sep 18;319(7212):731-4
pubmed: 10487995
Am J Health Promot. 2011 Nov-Dec;26(2):e64-73
pubmed: 22040398
Digestion. 2010;81(2):113-9
pubmed: 20093836
J Asthma. 2015;52(10):1084-91
pubmed: 26291135
Int J Nurs Stud. 2013 Jan;50(1):109-20
pubmed: 22560169
Kidney Int. 2011 Dec;80(12):1344-51
pubmed: 21832984
J Rheumatol. 1999 Oct;26(10):2114-22
pubmed: 10529126
Kidney Int. 2005 Oct;68(4):1777-83
pubmed: 16164654
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Patient Educ Couns. 1998 Mar;33(3):267-79
pubmed: 9731164
Plast Reconstr Surg. 2016 Oct;138(4):592e-602e
pubmed: 27673530
Am J Kidney Dis. 2012 Jul;60(1):102-11
pubmed: 22417786
Patient Educ Couns. 2011 Oct;85(1):53-9
pubmed: 20869188
Ren Fail. 2007;29(6):653-9
pubmed: 17763158
Diabetes Educ. 2010 Jul-Aug;36(4):586-94
pubmed: 20538970

Auteurs

Miriam Vélez-Bermúdez (M)

Department of Psychological & Brain Sciences, University of Iowa, Iowa City, Iowa.

Alan J Christensen (AJ)

Department of Psychological & Brain Sciences, University of Iowa, Iowa City, Iowa.
Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA.

Ellen M Kinner (EM)

Department of Psychological & Brain Sciences, University of Iowa, Iowa City, Iowa.

Anne I Roche (AI)

Department of Psychological & Brain Sciences, University of Iowa, Iowa City, Iowa.

Mony Fraer (M)

Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH